Abstract
Background There is limited information on the role of individuals in different age groups in the spread of infection during the Omicron epidemics, especially ones beyond the winter epidemic wave in 2021-2022. In England, booster vaccination against SARS-CoV-2 is currently restricted to persons aged over 50y and individuals in clinical risk groups.
Methods We used a previously developed methodology to evaluate the role of individuals in different age groups in propagating the Spring, Summer, and Autumn waves of the Omicron epidemic in England. This methodology utilizes the relative risk (RR) statistic that measures the change in the proportion of cases in each age group among all COVID-19 cases in the population before the peak of an epidemic wave vs. after the peak of an epidemic wave. Higher values for the RR statistic represent age groups that experienced a disproportionate depletion of susceptible individuals during the ascent of the epidemic (due to increased contact rates and/or susceptibility to infection).
Results For the 2022 Spring wave, the highest RR estimate belonged to children aged 5-9y (RR=2.05 (95%CI (2.02,2.08)), followed by children aged 10-14y (RR=1.68 (1.66,1.7)) and children aged 0-4y (RR=1.38 (1.36,1.41)). For the Summer wave, the highest RR estimates belonged to persons aged 20-34y: (RR=1.09 (1.07,1.12) in aged 20-24y, RR=1.09 (1.07,1.11) in aged 25-29y, RR=1.09(1.07,1.11) in aged 30-34y). For the Autumn wave, the highest RR estimate in adults belonged to those aged 70-74y (RR=1.10 (1.07,1.14)), followed by adults aged 35-39y (RR=1.09 (1.06,1.12)), adults aged 40-44y (RR=1.09 (1.06,1.12)), and adults aged 65-69y (RR=1.08 (1.05,1.11)) (with children excluded from the analyses due to limited/irregular detection of COVID-19 cases in children during the Autumn wave).
Conclusions As time progressed, ages of individuals who played the leading roles in propagating the Omicron epidemic waves in England shifted upward, with the leading roles in propagating COVID-19 epidemics in England currently belonging to adults of different ages. Extending booster vaccination to adults aged under 50y, and possibly to children should help limit the spread of Omicron infections in the community.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
edmigo3{at}gmail.com
Data Availability
This study is based on aggregate, de-identified publicly available data that can be retrieved through ref. 15.